Mid cap
Power Mech cuts MDO guidance by 30%, misses FY26 order inflow target
The engineering contractor trimmed its FY28 mine-development revenue forecast to ₹1,250 crore after client-side delays at SAIL. FY26 orders came in at ₹7,210 crore, well short of the ₹10,000 crore target.
Afcons posts first loss since 2010 as ₹260-265 cr provisions hit
MD apologised and withdrew FY27 guidance after quarterly loss of ₹89 cr, the first since 2010. Receivables stretch to 143 days.
Sudeep Pharma's Nandesari plant is delayed. Working capital is spiking.
Revenue grew 27.9% to ₹642.6 cr, but the working-capital cycle has blown out to 213 days. A delayed greenfield plant adds to the pressure.
Zydus Wellness Q4 transcript adds no new signals
The full concall transcript offers a verbatim account of management commentary but no new data beyond the prior summary.
Happy Forgings builds a ₹950 cr order book at prices 40% above today's average
A multi-year order pipeline at ₹340-350/kg gives Happy Forgings a visible earnings floor as it pivots from commercial vehicles to data-centre work.
Chalet's Q4 call: foreign room nights fell 9,000 as geopolitics bit
RevPAR dropped 3% in the March quarter, with management pinning the blame on geopolitical tensions that wiped out 9,000 international room nights.
WeWork India hits ₹80 cr profit, guides 20%+ revenue growth for FY27
Record occupancy of 86.9% drove a 142% profit jump. Management now expects earnings to grow faster than revenue in the current year.
IXIGO posts ₹715M profit on 34% revenue growth in FY26
Audited results match prior disclosures. Le Travenues' full-year revenue hit ₹12,280M, with a profit of ₹715M.
Alembic lands US launch for generic Synthroid into a $1.87bn market
Final USFDA approval lets Alembic sell immediately into the biggest thyroid-drug market in the US. The addressable market is more than double the company’s annual revenue.
India Glycols sues New India Assurance for ₹79.76 cr over 2020 plant damage
The company is in pre-institution mediation to recover the claim. The amount is 28% of its FY26 net profit.
Viyash Scientific posts record quarter, sets ₹800 cr EBITDA run-rate for FY27
Q4 revenue hit ₹920 crore and EBITDA jumped 64% to ₹200 crore. Management now sees the full-year EBITDA run-rate approaching ₹800 crore.
Transformers & Rectifiers lands ₹228 cr order from Gujarat utility
The GETCO contract equals 9.5% of the company's FY26 revenue, a material inflow for a mid-cap.
VA Tech Wabag wins repeat Delhi Jal Board contract for 17-MGD wastewater plant
The design-build-operate order is worth ₹100–250 crore and locks in 15 years of operations work after a 21-month build.
Engineers India profit jumps 53% on near-doubled revenue
FY26 standalone results show revenue surging to ₹3,845.92 cr and net profit to ₹639.74 cr. The board has proposed a ₹2.50 final dividend on top of the interim already paid.
Black Box board to approve Q4 results and weigh dividend, fund raise
A standard pre-results notice. The filing gives a date and agenda, but no numbers.
Apollo Micro sees large defence orders this year after record quarter
MD outlines a path to global OEM status by 2036 as the order book hits ₹1,432 cr. A subsidiary acquisition should close this FY.
Reliance Power auditor flags going-concern risk as it books a ₹337 cr loss
A swing to a net loss, qualified subsidiary audits, and a warning from the auditor about the group's ability to continue.
Reliance Power swings to ₹337 cr loss, seeks ₹9,000 cr from shareholders
FY26 profit evaporated without a one-time gain. The board now wants approval for a capital raise equal to 80% of its market cap.
VA Tech Wabag's ₹172 bn order book is the headline in a routine results deck
A supplementary presentation on already-disclosed FY26 results adds detail but no new material. The company's order backlog is at a record and it remains cash positive.
Bikaji's audited Q4 shows profit up 40% on strong volume
The snack-maker's full results confirm the headline numbers from May 21. Double-digit volume growth is the key signal.
India Tourism Development Corporation posts steady profit despite qualified audit
Board recommends ₹2.95 per share dividend as recurring governance and accounting gaps persist.
Hindustan Foods' press release repeats every number from the audited filing
Total income of ₹4,264.7 cr, PAT of ₹149 cr, and ₹200–220 cr FY27 guidance were all already disclosed.
Hindustan Foods bets ₹150 crore on new capacity after record year
Contract manufacturer hits ₹104 crore quarterly EBITDA record and sticks to its ₹200-220 crore FY27 profit target.
Dr. Agarwal's Health Care reports FY26 revenue of over ₹2,000 cr
The company confirms FY26 growth targets with plans to add 60 new facilities in FY27 at a cost of up to ₹400 cr.
Bikaji Foods grows FY26 revenue by 11.5% to ₹2,758 crore
Net profit rose 28% to ₹269 crore as the company sticks to a final dividend of ₹1.25 per share.